Nucleoside triphosphates (NTPs) are vital components of emerging RNA therapeutics and vaccines. Controlling impurities that may be present in them while understanding key product quality attributes that make them suitable for good manufacturing practice (GMP) production is important for the successful development of these therapeutics and vaccines.
Download this white paper to help you recognize major impurities and identify quality attributes when looking for GMP-quality NTPs.
- Impurity profiling and analysis of TheraPure GMP nucleotides
- Quality and consistency of N1-methylpseudouridine triphosphate
